DeFiWeekly

Vote here for Trump

Vote here for Trump

Who is voting for President Trump again? #Trump #Iran #Israel

@NotQuiteARKK Great work! Hoping $RIVN reaches $700. I have a position.

There is no #inflation. There is no #jobloss. Its a dual mandate.

BREAKING: BTC breaks above $68,000 and ETH breaks above $2,000. Bitcoin is up 5% in just 50 minutes, adding $60 billion to its market cap. Ethereum is up 5.8% in just 50 minutes, adding $23 billion to its market cap. The Crypto market has added $100 billion in the last 45 minutes, liquidating nearly $80 million in short positions.

💥BREAKING: $120,000,000,000 has been added to the crypto market in just 60 minutes.

@_falsi1ke Hello

No account should be under 1K followers Say hello, I will boost you

@NotQuiteARKK Great analysis as always. $HIMS

$HIMS : SCALING DIGITAL HEALTH FOR A NEW GENERATION HIMS stock has been under significant pressure recently, largely due to regulatory and legal developments and has corrected more than 80% from its peak. WHAT ARE INVESTORS WORRIED ABOUT... THE NEGATIVES Four (4) things — FDA action, SEC probe, Big‑pharma legal risk and Q1 2026 guidance. FDA: FDA removed legal footing that previously allowed some compounded semaglutide weight‑loss drugs, a key revenue driver, leading to product withdrawals SEC Probe: U.S. SEC has launched an inquiry into disclosure practices regarding some products Big‑pharma Legal Risk: A patent lawsuit from industry leader Novo Nordisk over semaglutide copycat products in a major growth category Q1 2026 Guidance: Soft guidance. All of the above have led to HIMS correcting ~80% from its recent peak. However, they have posted record revenue figures with +59% YoY and positive net income. HOW IS MANAGEMENT TACKLING ISSUES... THE POSITIVES HIMS leadership has publicly framed the situation as a longer‑term growth reset and are taking following actions: International Expansion: Large acquisitions like Eucalyptus to enter new markets (Australia, UK, Europe, Canada, Japan). This could unlock new revenue streams outside the U.S. and lessen dependence on regulated products. Diversification Beyond GLP‑1 Drugs: Growing sexual health, dermatology, mental health, and preventative care offerings. Subscriber Growth: This has continued and monthly revenue per subscriber has improved which shows that the core digital health business still scales. Pivot: A pivot toward broader telehealth rather than reliance on a single drug category. TECHNICALS - Price reached 1.618 FiB level target of $65, of the total down move from Year 21-22, giving a return of more than 20X. A price target where 80% of swing trade profit was taken. - Price formed a distributive pattern from Feb 2025 to Oct 2025. - Price broke both the uptrend line as well as Weekly 50 MA at $43 during its recent correction, both of which were held during the entirety of upmove from $8 to $70. This was a big red flag. Why this current area of ~$12-$14 is a solid buy level for a solid bounce? - Price is currently at confluence of a diagonal "One line to rule them all" and "Buy area for a bounce". - Weekly RSI is in very oversold territory and has never been this low. - Price has corrected ~80% from its peak without any reasonable bounce. This doesn't mean stock price cannot go further down, but it is a solid place for a bounce for at least > $21 price which can give a quick 50% return. HOW I PLAN TO PLAY THIS I personally really like it a lot as Hims & Hers addresses everyday health concerns that are increasingly prevalent, including hair loss, weight management, sexual health, and mental wellness. Their solutions are designed for adults aged 25–45, a demographic that is digitally savvy, highly engaged with telehealth, and actively seeking convenient, accessible care. By targeting common & growing health challenges, HIMS is positioning itself as a major player through intersection of healthcare and technology. Therefore, I will keep DCAing from this level & below as I feel it is a good buy for a long term as I align with the problems they are trying to solve which are only going to increase henceforth for our and upcoming generations.

JUST IN: $PLTR up 0.92% to $137.20 after UBS upgrades from Neutral to Buy with $180 price target. UBS says "Our latest checks supports a view that Palantir is facing a very strong demand backdrop". UBS sets 70% revenue growth target for 2026.

JUST IN: CME Group's FedWatch tool shows 95.7% chance of no interest rate cut. $BTC fell to $63,000 then recovered to $66,000. President Trump has spoken out against Federal Reserve Chair Jerome Powell.

JUST IN: Bank of America says Kinross Gold Corp stock ($KGC) is enroute to hit $42.75. $KGC closed Friday at $36.99. $GOLD prices climbed 120 points to $5,400.

JUST IN: $AAPL falls 3.21% to $264.18. MoffettNathanson raises 12-month target to $270, keeps Neutral stance. Wedbush targets $350, Sanford C. Bernstein targets $340.

JUST IN: $BTC fell to $63,000 on Feb 28, 2026, after US and Israel's strike on Iran. $BTC has risen 3% in the last week, but fallen 0.7% in the last 24 hours and over 20% in the last month. $BTC has substantial support at $62,000-$63,000.

JUST IN: $XRP fell to $1.28 on Feb 28, 2026. $XRP price has fallen by 3.7% in the last 24 hours. $XRP price has fallen by 22% over the previous month. CoinCodex analysts say $XRP will not go beyond $1.57 till at least May 31, 2026. $BTC fell to $63,000.

🇺🇸 Jim Cramer says American Bitcoin investors could potentially "lose everything." 👀

🚨BREAKING NEWS The Iranian Revolutionary Guard has released new footage. The footage shows a tunnel containing unmanned aerial vehicles and firing at US bases.

$8 BILLION INVESTING LEGEND CATHIE WOOD JUST DROPPED AN ABSOLUTE BOMBSHELL SHE SAYS PRESIDENT TRUMP WILL PASS 0% CAPITAL GAINS ON #BITCOIN PAYMENTS THIS YEAR "IT WILL BE BEFORE THE MIDTERM ELECTIONS" YOU'VE BEEN WARNED 🚀

JUST IN: 🇸🇦 Iran strikes Saudi Arabia's Aramco Ras Tanura oil refinery.

JUST IN: $GOLD is up 2% and has added $750B to its market cap. $SILVER is up 2.10% and has added $112B. Rashad Hajiyev says "What if a war in the Middle East is going to be a trigger for the start of a parabolic run in the precious metals".